INDV - INDIVIOR PLC
32.97
-0.570 -1.729%
Share volume: 1,112,565
Last Updated: 01-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$33.54
-0.57
-0.02%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-26-2026 | |
| Total revenue | 266.000 M | 302.000 M | 314.000 M | 357.000 M | |
| Cost of revenue | 44.000 M | 52.000 M | 83.000 M | 67.000 M | |
| Gross profit | 221.000 M | 250.000 M | 230.000 M | 293.000 M | |
| 13.12% | -8.00% | 27.39% | |||
| Operating expenses | 154.000 M | 179.000 M | 188.000 M | 210.000 M | |
| Selling general and admin | 132.000 M | 158.000 M | 155.000 M | 189.000 M | |
| Research and development | 22.000 M | 21.000 M | 33.000 M | 21.000 M | |
| Total expenses | 155.000 M | 179.000 M | 187.000 M | 210.000 M | |
| 15.48% | 4.47% | 12.30% | |||
| Operating income | 66.000 M | 72.000 M | 43.000 M | 81.000 M | |
| Ebit | 66.000 M | 72.000 M | 43.000 M | 81.000 M | |
| Pretax income | 59.000 M | 62.000 M | 37.000 M | 81.000 M | |
| 5.08% | -40.32% | 118.92% | |||
| Income tax | 11.000 M | 44.000 M | -5.000 M | -21.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 47.000 M | 18.000 M | 42.000 M | 103.000 M | |
| -61.70% | 133.33% | 145.24% |